跳至主要内容
临床试验/ACTRN12620000197932
ACTRN12620000197932
已完成
未知

A randomised controlled trial comparing the clinical pregnancy per embryo transfer between an embryo that is selected by an artificial intellligence system (iDA) and and an embryo that is selected by an embryologist.

Vitrolife0 个研究点目标入组 1,066 人2020年2月20日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Infertility
发起方
Vitrolife
入组人数
1066
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2020年2月20日
结束日期
2022年9月30日
最后更新
2年前
研究类型
Interventional
性别
Female

研究者

发起方
Vitrolife

入排标准

入选标准

  • Inclusion Criteria
  • 1\)Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins and the intention to treat by either transfer of a single fresh embryo on Day 5 or in case of a freeze all cycle, the first rewarmed embryo.
  • 2\)Age: Up to and including the 42nd completed birthday on the day of randomization.
  • 3\)Has at least two early blastocysts on Day 5

排除标准

  • Exclusion Criteria
  • 1\)Treatment involving donated eggs
  • 2\)Intention to perform any form of preimplantation genetic testing
  • 3\)IMSI patients
  • 4\)Previous participation in this RCT
  • 5\)Where the cycle is carried out for fertility preservation.
  • 6\)If a Day 2\-4 transfer is planned
  • 7\)Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by either:
  • An AMH level of \<3pmol/L or AFC \<5 (if available)

结局指标

主要结局

未指定

相似试验